Hvivo
Hvivo, a leading clinical research organisation headquartered in Great Britain, specialises in the development and testing of innovative therapies and vaccines. Founded in 2006, the company has established itself as a pioneer in the field of human challenge studies, providing unique insights into infectious diseases. With operational hubs across Europe and North America, Hvivo offers a range of services, including clinical trial management and laboratory services, that are tailored to meet the needs of biopharmaceutical clients. Notable for its state-of-the-art facilities and expertise in respiratory and viral infections, Hvivo has achieved significant milestones, including partnerships with major pharmaceutical companies. Its commitment to advancing medical research positions Hvivo as a trusted partner in the industry, driving forward the development of life-saving treatments and vaccines.
DitchCarbon Score
How does Hvivo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hvivo's score of 34 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hvivo's reported carbon emissions
In 2024, hVIVO reported total carbon emissions of approximately 192,400 kg CO2e. This figure includes Scope 1 emissions of about 14,900 kg CO2e, primarily from stationary combustion, and Scope 2 emissions of around 162,800 kg CO2e from purchased electricity. Additionally, Scope 3 emissions, which encompass business travel, accounted for about 14,700 kg CO2e. Comparatively, in 2023, hVIVO's total emissions were approximately 148,100 kg CO2e, with Scope 1 emissions at about 12,600 kg CO2e, Scope 2 emissions at around 78,200 kg CO2e, and Scope 3 emissions reaching approximately 57,300 kg CO2e. The 2022 data shows a total of about 104,300 kg CO2e, with Scope 1 emissions of approximately 63,800 kg CO2e, Scope 2 emissions of about 12,900 kg CO2e, and Scope 3 emissions of around 27,600 kg CO2e. Despite these emissions figures, hVIVO has not set specific reduction targets or climate pledges, nor do they have any initiatives reported under the Science Based Targets initiative (SBTi). The company does not inherit emissions data from a parent organization, indicating that all reported figures are self-contained. Overall, hVIVO's emissions data reflects a growing trend in carbon output, highlighting the need for strategic climate commitments and reduction initiatives in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 63,800 | 00,000 | 00,000 |
| Scope 2 | 12,900 | 00,000 | 000,000 |
| Scope 3 | 27,600 | 00,000 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hvivo is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
